A Mathematical Tumor Model with Immune Resistance and Drug Therapy: An Optimal Control Approach
From MaRDI portal
Publication:2767515
DOI10.1080/10273660108833067zbMath0985.92023OpenAlexW2013304036MaRDI QIDQ2767515
L. G. de Pillis, A. E. Radunskaya
Publication date: 30 May 2002
Published in: Journal of Theoretical Medicine (Search for Journal in Brave)
Full work available at URL: https://eudml.org/doc/226953
Applications of optimal control and differential games (49N90) Medical applications (general) (92C50)
Related Items
Dynamical behaviour of a tumour-immune model focusing on the dosage of targeted chemotherapeutic drug, AN ADAPTIVE PHARMACOKINETIC OPTIMAL CONTROL APPROACH IN CHEMOTHERAPY FOR HETEROGENEOUS TUMOR, THE EFFECT OF LENVATINIB AND PEMBROLIZUMAB ON THYROID CANCER REFRACTORY TO IODINE 131I SIMULATED BY MATHEMATICAL MODELING, Dynamics of a Mathematical Model of Cancer and Immunoediting Scenarios Under the Variation of the Immune Cell Activation Rate, Bifurcation and chaos analysis of tumor growth, Unnamed Item, Constrained bilinear control problem: Application to a cancer chemotherapy model, A nonlinear transport-diffusion model for the interactions between immune system cells and HPV-infected cells, Learning-based sensitivity analysis and feedback design for drug delivery of mixed therapy of cancer in the presence of high model uncertainties, Mathematical modeling and bifurcation analysis for a biological mechanism of cancer drug resistance, A mathematical model of stroma-supported allometric tumor growth, Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent, Optimal control homotopy perturbation method for cancer model, Robust feedback design for combined therapy of cancer, Developing and studying the dynamical behavior of a nonlinear mathematical model for cancers with tumor by considering immune system role, Optimal chemotherapy in cancer treatment: state dependent Riccati equation control and extended Kalman filter, Bifurcation Analysis in a Cancer Growth Model, Fractional order model of immune cells influenced by cancer cells, The effect of finite duration inputs on the dynamics of a system: Proposing a new approach for cancer treatment, Bifurcation analysis of the cancer virotherapy system with time delay and diffusion, Bifurcation, multistability in the dynamics of tumor growth and electronic simulations by the use of Pspice, Identifying and characterising the impact of excitability in a mathematical model of tumour-immune interactions, Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes, Analysis of the dynamics of a tumor-immune system with chemotherapy and immunotherapy and quadratic optimal control, Is the Allee effect relevant in cancer evolution and therapy?, Investigating of an immune system-cancer mathematical model with Mittag-Leffler kernel, Personalized drug administration for cancer treatment using model reference adaptive control, Role of immunotherapy in tumor-immune interaction: perspectives from fractional-order modelling and sensitivity analysis, Effects of the obesity on optimal control schedules of chemotherapy on a cancerous tumor, Combination therapies and intra-tumoral competition: insights from mathematical modeling, A time delay model of tumour-immune system interactions: global dynamics, parameter estimation, sensitivity analysis, Mathematical modelling and analysis of the tumor treatment regimens with pulsed immunotherapy and chemotherapy, Optimal Control of Cancer Treatments: Mathematical Models for the Tumor Microenvironment, Optimal control problem for a general reaction-diffusion tumor-immune interaction system of mixed immunotherapy and chemotherapy, Optimal control with isoperimetric constraint for chemotherapy of tumors, Sliding mode control in a mathematical model to chemoimmunotherapy: the occurrence of typical singularities, Phase-specific cancer-immune model considering acquired resistance to therapeutic agents, The tumor growth paradox and immune system-mediated selection for cancer stem cells, The chaos and optimal control of cancer model with complete unknown parameters, Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment, Adaptive backstepping controller design for MIMO cancer immunotherapy using Laguerre polynomials, Assessing the effects of estrogen on the dynamics of breast cancer, Iterative method for estimating the robust domains of attraction of non-linear systems: application to cancer chemotherapy model with parametric uncertainties, Multi-input optimal control problems for combined tumor anti-angiogenic and radiotherapy treatments, Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations, A cellular automata model of tumor-immune system interactions, Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function, An immune system-tumour interactions model with discrete time delay: model analysis and validation, Interactions between the immune system and cancer: A brief review of non-spatial mathematical models, New observations on optimal cancer treatments for a fractional tumor growth model with and without singular kernel, Influence of distributed delays on the dynamics of a generalized immune system cancerous cells interactions model, On a multiobjective optimal control of a tumor growth model with immune response and drug therapies, Chaos in a tumor growth model with delayed responses of the immune system, Cancer cell eradication in a 6D metastatic tumor model with time delay, Global dynamics of a breast cancer competition model, Optimization of interleukin-21 immunotherapeutic strategies, Global stability analysis and optimal control therapy of blood cell production process (hematopoiesis) in acute myeloid leukemia, Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine, A two-phenotype model of immune evasion by cancer cells, Modelling lymphoma therapy and outcome, Bounding the dynamics of a chaotic-cancer mathematical model, Cancer immunotherapy, mathematical modeling and optimal control, Stability of a Mathematical Model with Piecewise Constant Arguments for Tumor-Immune Interaction Under Drug Therapy, Can the original equations of a dynamical system be retrieved from observational time series?, Optimal CAR T-cell immunotherapy strategies for a leukemia treatment model, The dynamics of an optimally controlled tumor model: A case study, Optimal control problem for a general reaction-diffusion tumor-immune system with chemotherapy, Dynamical behaviour of a tumor-immune system with chemotherapy and optimal control, Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls, Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics, The combined effects of optimal control in cancer remission, Mathematical analysis of a tumour-immune interaction model: a moving boundary problem, Global solvability and optimal control to a haptotaxis cancer invasion model with two cancer cell species, Analysis of the effectiveness of the treatment of solid tumors in two cases of drug administration, Chaos and optimal control of cancer self-remission and tumor system steady states, Optimal control for a mathematical model of glioma treatment with oncolytic therapy and TNF-\(\alpha \) inhibitors, Stability and bifurcation analysis of a mathematical model for tumor-immune interaction with piecewise constant arguments of delay, Cost-effectiveness analysis of optimal strategy for tumor treatment, Robust domain of attraction estimation for a tumor growth model, Predictive drug dosage control through a Fokker-Planck observer, Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens, Extinction and persistence of a tumor-immune model with white noise and pulsed comprehensive therapy, Computational modeling of tumor response to vascular-targeting therapies. I: Validation, Dynamic analysis of a tumor-immune system under Allee effect, A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia, Delay differential model for tumour-immune response with chemoimmunotherapy and optimal control, Optimal control of tumour-immune model with time-delay and immuno-chemotherapy, Spatial avascular growth of tumor in a homogeneous environment, On the role of the objective in the optimization of compartmental models for biomedical therapies, On the role of pharmacometrics in mathematical models for cancer treatments, Periodic and chaotic dynamics in a map-based model of tumor-immune interaction, Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis, Targeting the quiescent cells in cancer chemotherapy treatment: is it enough?, A mathematical model for the effect of obesity on cancer growth and on the immune system response, Modelling of tumor cells regression in response to chemotherapeutic treatment, A cancer model for the angiogenic switch, On probabilistic certification of combined cancer therapies using strongly uncertain models, Application of control theory in a delayed-infection and immune-evading oncolytic virotherapy, Dynamics of tumor growth: chemotherapy and integrative oncology, Mathematical modeling and dynamic analysis of anti-tumor immune response, Insights into the dynamics of blood conveying gold nanoparticles on a curved surface when suction, thermal radiation, and Lorentz force are significant: the case of non-Newtonian Williamson fluid, A two-compartment model interacting with dynamic drugs, Modeling the virus-induced tumor-specific immune response with delay in tumor virotherapy, Combination of virotherapy and chemotherapy with optimal control for combating cancer, On optimal delivery of combination therapy for tumors, A multi-drug pharmacokinectic optimal control approach in cancer chemotherapy, Numerical optimal control of a size-structured PDE model for metastatic cancer treatment, Efficiency of cancer treatments: in silico experiments, Effects of delayed immune-activation in the dynamics of tumor-immune interactions, Optimal control for a mathematical model for chemotherapy with pharmacometrics, Dynamics of breast cancer under different rates of chemoradiotherapy, Two-compartment model interacting with proliferating regulatory factor, Mathematical models of leukaemia and its treatment: a review, Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control, A dynamic simulation of the immune system response to inhibit and eliminate abnormal cells, A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER, Unnamed Item, Effects of delay in a biological environment subject to tumor dynamics, Optimal bounded controls problem for bilinear systems
